HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xuefang Pan Selected Research

serine carboxypeptidase

1/2017Mice, double deficient in lysosomal serine carboxypeptidases Scpep1 and Cathepsin A develop the hyperproliferative vesicular corneal dystrophy and hypertrophic skin thickenings.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xuefang Pan Research Topics

Disease

3Atherosclerosis
01/2021 - 09/2011
2Memory Disorders (Memory Loss)
01/2022 - 01/2017
2Mucolipidoses (Sialidosis)
01/2021 - 07/2013
1Mucopolysaccharidoses
01/2022
1Mucopolysaccharidosis III (Sanfilippo Syndrome)
01/2022
1Atherosclerotic Plaque (Atheroma)
01/2021
1Vascular Diseases (Vascular Disease)
01/2021
1Coronary Artery Disease (Coronary Atherosclerosis)
01/2021
1Infections
12/2018
1Muscular Diseases (Myopathy)
12/2018
1Neoplasm Metastasis (Metastasis)
12/2018
1Sialic Acid Storage Disease (Salla Disease)
12/2018
1Hyperglycemia
01/2018
1Insulin Resistance
01/2018
1Glucose Intolerance
01/2018
1Gliosis
01/2017
1Nervous System Diseases (Neurological Disorders)
01/2017
1Gangliosidoses (Gangliosidosis)
01/2017
1Hereditary Corneal Dystrophies
01/2017
1Tay-Sachs Disease
01/2017
1Hypertension (High Blood Pressure)
01/2017
1Neuroinflammatory Diseases
01/2017
1Prion Diseases (Transmissible Spongiform Encephalopathies)
01/2015
1Hepatocellular Carcinoma (Hepatoma)
01/2014
1of Schnyder Crystalline Corneal Dystrophy
01/2014
1Carcinogenesis
10/2005

Drug/Important Bio-Agent (IBA)

3Neuraminidase (Sialidase)IBA
01/2021 - 01/2017
3Apolipoproteins E (ApoE)IBA
01/2021 - 09/2011
3ApolipoproteinsIBA
01/2021 - 09/2011
2CholesterolIBA
01/2021 - 01/2014
2GlycolipidsIBA
01/2021 - 12/2018
2Glycoproteins (Glycoprotein)IBA
01/2021 - 12/2018
2LDL Receptors (LDL Receptor)IBA
01/2021 - 09/2011
2Cathepsin AIBA
01/2018 - 01/2017
2Insulin (Novolin)FDA Link
01/2018 - 07/2013
1AcetyltransferasesIBA
01/2022
1Glucosamine (Dona)IBA
01/2022
1Acetyl Coenzyme A (Acetyl-CoA)IBA
01/2022
1Heparitin Sulfate (Heparan Sulfate)IBA
01/2022
1LDL Lipoproteins (beta Lipoproteins)IBA
01/2021
1ethyl gallateIBA
01/2021
1oxidized low density lipoproteinIBA
01/2021
1Apolipoprotein B-100 (Apo B 100)IBA
01/2021
1Asialoglycoprotein ReceptorIBA
01/2021
1N-Acetylneuraminic Acid (Sialic Acid)IBA
01/2021
1Benzoates (Benzoate)IBA
01/2021
1Polysaccharides (Glycans)IBA
01/2021
1Lysergic Acid Diethylamide (LSD)IBA
01/2021
1LipidsIBA
01/2021
1N-acetylneuraminate lyaseIBA
12/2018
1AcetylglucosamineIBA
12/2018
1Sialic AcidsIBA
12/2018
1Ambroxol (Mucosolvan)IBA
01/2018
1PalmitatesIBA
01/2018
1Proteins (Proteins, Gene)FDA Link
01/2018
1Insulin ReceptorIBA
01/2018
1EnzymesIBA
01/2017
1GangliosidesIBA
01/2017
1G(M3) GangliosideIBA
01/2017
1G(M1) GangliosideIBA
01/2017
1LipofuscinIBA
01/2017
1CarboxypeptidasesIBA
01/2017
1Serine (L-Serine)FDA Link
01/2017
1serine carboxypeptidaseIBA
01/2017
1SialoglycoproteinsIBA
01/2015
1Prion ProteinsIBA
01/2015
1Phospholipids (Phosphatides)FDA LinkGeneric
01/2014
1Protein Kinases (Protein Kinase)IBA
07/2013
1Carrier Proteins (Binding Protein)IBA
09/2011
1Adenosine Triphosphate (ATP)IBA
10/2005

Therapy/Procedure

1Transplantation
09/2011